Last updated on November 2018

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men


Brief description of study

This will be a randomized, multicenter, open-label, active-controlled, efficacy, and safety study in adult hypogonadal men. The study duration is 12 months (365 days), including a 90-day, open-label efficacy period and a 9-month (275-day) safety evaluation period.

Clinical Study Identifier: NCT03198728

Contact Investigators or Research Sites near you

Start Over

Meridien Research
Bradenton, FL United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.